TransGenex Nanobiotec Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 4

TransGenex Nanobiotec General Information

Description

Developer of nano-scale technologies for diagnostic and therapeutic agents against cancers and other inflammatory diseases. The company develops fiber-inspired scaffold technology platform that enables development of multicellular tumor spheroids that fully resemble tumors in vivo, resulting in improved drug discovery and development, as well as better prediction of the clinical efficacy of drugs for personalized cancer treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • 13719 North Nebraska Avenue
  • Suite 108
  • Tampa, FL 33613
  • United States
+1 (813) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TransGenex Nanobiotec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 18-Jun-2015 Completed Generating Revenue
3. Grant 01-Jan-2015 00.000 Completed Generating Revenue
2. Grant 01-Jan-2009 $427K Completed Startup
1. Grant 01-Jan-2008 $1.03M Completed Startup
To view TransGenex Nanobiotec’s complete valuation and funding history, request access »

TransGenex Nanobiotec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of nano-scale technologies for diagnostic and therapeutic agents against cancers and other inflammatory diseas
Biotechnology
Tampa, FL
9 As of 2016
000000000000

00000000

smod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerc
0000000000000
Schlieren, Switzerland
00 As of 0000
000.00
0000 000.00

0000000

uptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proi
0000000000000
San Francisco, CA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TransGenex Nanobiotec Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSphero Formerly VC-backed Schlieren, Switzerland 00 000.00 0000 000.00
0000000 000000000 Venture Capital-Backed San Francisco, CA 00 000.00 0000000000 0 000.00
00 000000 Corporate Backed or Acquired Bridgewater, NJ 000000&0
000000 0000000000 Venture Capital-Backed Vancouver, Canada 00 000.00 00000000000 000.00
To view TransGenex Nanobiotec’s complete competitors history, request access »

TransGenex Nanobiotec Executive Team (5)

Name Title Board Seat Contact Info
Shyam Mohapatra Ph.D Co-Founder & Board Member
Bernard Skerkowski Vice President, Finance
Chandresh Saraiya MD Vice President, Medical Affairs
You’re viewing 3 of 5 executive team members. Get the full list »

TransGenex Nanobiotec Board Members (2)

Name Representing Role Since
Shyam Mohapatra Ph.D TransGenex Nanobiotec Co-Founder & Board Member 000 0000
Subhra Mohapatra Ph.D TransGenex Nanobiotec Co-Founder & Advisory Board Member 000 0000
To view TransGenex Nanobiotec’s complete board members history, request access »

TransGenex Nanobiotec Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TransGenex Nanobiotec Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Florida Institute for the Commercialization of Public Research Not-For-Profit Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view TransGenex Nanobiotec’s complete investors history, request access »